project id: TCGA-SARC; case submitter id: TCGA-LI-A67I; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.26; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.85; rna integrity number: 8.9; age at index: 75; days to birth: -27671; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 27671; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 922.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8811/3; primary diagnosis: Fibromyxosarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 90; days to sample procurement: 0; initial weight: 1610.0; portion submitter id: TCGA-LI-A67I-01A-31; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;